Fill in the missing piece on your journey to publication Enter the draw

Glutamate Site

Code

Name

Details

 Image Abreview Publication 

Alaproclate hydrochloride 

Potent, selective serotonin uptake inhibitor. Potent, reversible, noncompetitive NMDA antagonist.

Purity: > 95%

 
 
 
 

D-AP5 

NMDA glutamate site antagonist

Purity: > 99%

Images
 
Specific publication references
 
 
 

DL-AP5 

NMDA glutamate site antagonist

Purity: > 99%

 
Specific publication references
 
 
 

DL-AP5 sodium salt 

NMDA glutamate site antagonist. Water soluble form.

Purity: > 99%

 
Specific publication references
 
 
 

CGP 37849 

Competitive NMDA antagonist

Purity: > 99%

 
Specific publication references
 
 
 

CGP 39551 

Competitive NMDA antagonist

Purity: > 99%

 
Specific publication references
 
 
 

(R)-CPP 

Potent NMDA antagonist

 
Specific publication references
 
 
 

(R,S)-CPP 

Potent NMDA antagonist

 
 
 
 

(R)-CPPene (SDZ EAA 494) 

Potent competitive NMDA antagonist

Purity: > 98%

 
 
 
 

Gentiopicroside (Gentiopicrin) 

Anticonvulsant agent

Purity: > 98%

 
 
 
 

IEM-1460 

Selective GluR2 lacking AMPA receptor blocker. Open channel blocker.

 
 
 
 

NMDA 

Excitotoxic amino acid

Purity: > 99%

Images
 
Specific publication references
 
 
 

cis-PPDA 

GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist

Purity: > 98%

 
Specific publication references
 
 
 

Rhyncholphylline 

Ca2+ channel blocker. Non-competitive NMDA antagonist.

Purity: > 98%

 
 
 
 

UBP141 

GluN2D (formerly NR2D) antagonist, with some subunit selectivity

Purity: > 98%

 
Specific publication references